The MAPK/ERK1/2 pathway is one of the three canonical pathways triggered by leptin [30], which is associated with the leptin-mediated growth and metastasis of various epithelial-derived cancers [38,52] and NC-derived astrocytoma [53]. The gene discussed is LEP; the disease is astrocytoma (excluding glioblastoma).